Open Access
| Issue |
MATEC Web Conf.
Volume 404, 2024
2024 2nd International Conference on Materials Engineering, New Energy and Chemistry (MENEC 2024)
|
|
|---|---|---|
| Article Number | 04009 | |
| Number of page(s) | 7 | |
| Section | Pharmaceuticals, Environmental Science, and Toxicology | |
| DOI | https://doi.org/10.1051/matecconf/202440404009 | |
| Published online | 24 October 2024 | |
- D. Jeffreys, Aspirin: The Remarkable Story of a Wonder Drug. Bloomsbury Publishing, New York, NY, (2005) [Google Scholar]
- J. Hybiak, I. Broniarek, G. Kiryczyński, et al. Aspirin and its pleiotropic application. European Journal of Pharmacology 866, 172762 (2020) [CrossRef] [Google Scholar]
- C. Patrono, J. Morais, C. Baigent, et al. Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. Journal of the American College of Cardiology 70, 1760-1776 (2017) [CrossRef] [Google Scholar]
- N. R. Cook, I.-M. Lee, S. M. Zhang, et al. Low-Dose Aspirin and Cancer Risk: LongTerm Observational Follow-up of a Randomized Trial. Ann Intern Med 159, 77 (2013) [CrossRef] [Google Scholar]
- B. Glatthaar-Saalmüller, K. H. Mair, & A. Saalmüller, Antiviral activity of aspirin against RNA viruses of the respiratory tract-an in vitro study. Influenza Resp Viruses 11, 85-92 (2017) [CrossRef] [Google Scholar]
- E. Murphy, J. M. G. Curneen, & J. W. McEvoy, Aspirin in the Modern Era of Cardiovascular Disease Prevention. Methodist DeBakey Cardiovascular Journal 17, 36-47 (2021) [CrossRef] [Google Scholar]
- V. Fuster, & J. M. Sweeny, Aspirin: a historical and contemporary therapeutic overview. Circulation 123, 768-778 (2011) [CrossRef] [Google Scholar]
- J. Sweeny, D. Gorog, & V. Fuster, Antiplatelet drug “resistance,” part 1: mechanisms and clinical measurements. (2009) [Google Scholar]
- P. Elwood, M. Protty, G. Morgan, et al. Aspirin and cancer: biological mechanisms and clinical outcomes. Open Biol. 12, 220124 (2022) [CrossRef] [Google Scholar]
- P. M. Rothwell, M. Wilson, C. E. Elwin, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. The Lancet 376, 1741-1750 (2010) [CrossRef] [Google Scholar]
- E. Ricciotti, & G. A. FitzGerald, Aspirin in the Prevention of Cardiovascular Disease and Cancer. Annu. Rev. Med. 72, 473-495 (2021) [CrossRef] [Google Scholar]
- A. M. Algra, & P. M. Rothwell, Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. The Lancet Oncology 13, 518-527 (2012) [CrossRef] [Google Scholar]
- H. Khan, O. Kanny, M. H. Syed, Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy. IJMS 23, 11317 (2022) [CrossRef] [Google Scholar]
- C. N. Floyd, & A. Ferro, Mechanisms of aspirin resistance. Pharmacology & Therapeutics 141, 69-78 (2014) [CrossRef] [Google Scholar]
- E. I. Lev, A. Solodky, N. Harel, et al. Treatment of Aspirin-Resistant Patients With Omega-3 Fatty Acids Versus Aspirin Dose Escalation. Journal of the American College of Cardiology 55, 114-121 (2010) [CrossRef] [Google Scholar]
- Y. Zhao, S. Yang, & M. Wu, Mechanism of Improving Aspirin Resistance: BloodActivating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases. Front Pharmacol 12, 794417 (2021) [CrossRef] [Google Scholar]
- L. A. García Rodríguez, M. Martín-Pérez, C. H. Hennekens, et al. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies. PLoS ONE 11, e0160046 (2016) [CrossRef] [Google Scholar]
- E. S. Huang, L. L. Strate, W. W. Ho, et al. Long-Term Use of Aspirin and the Risk of Gastrointestinal Bleeding. The American Journal of Medicine 124, 426-433 (2011) [CrossRef] [Google Scholar]
- A. Lanas, L. A. García-Rodríguez, M. T. Arroyo, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional nonaspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 55, 1731-1738 (2006) [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.